Navigation Links
Three prominent Cell Press journals named among the 100 most influential journals in past 100 years

CAMBRIDGE, Mass., USA (April 6, 2009) Cell Press, an imprint of Elsevier, announced today that its flagship journal, Cell, as well as Current Biology and The American Journal of Human Genetics, were voted among the Special Library Association's (SLA) Top 100 Journals in Biology and Medicine of the past century.

The Top 100 list is compiled by the 680-plus members of the SLA's Biomedical and Life Sciences Division (DBIO) on the most influential journals in biology and medicine over the last century. The "Journal of the Century" and the Top Ten journal titles will be announced at the Centennial Conference of the Special Libraries Association on June 16th in Washington, D.C.

"We are honoured to be recognized by the SLA for influence and impact in biology, on behalf of Cell Press' two titles Cell and Current Biology, and on behalf of our publishing partner, the American Society of Human Genetics, for the AJHG," said Lynne Herndon, President and CEO of Cell Press.

Established in 1909 to serve a 'specialized' clientele in business, government, social agencies, and academia, the SLA is now an 11,000 member professional organization of subject specialist librarians, information managers, and publishing industry representatives. Each topical division has contributed a Centennial-themed event throughout the year. In 2008, the BioMedical & Life Sciences Division (DBIO) convened an international panel of nine eminent subject experts to compile a ballot for an electronic poll of SLA members concerning the 100 most influential journals of biology and medicine over the 100 years of SLA's existence.

Cell, the pioneer Cell Press title, published its first issue in 1974, and has become one of the most highly-respected and prominent journals in the field. This journal publishes exciting and significant developments in the biological sciences, including cell biology, neuroscience, immunology, virology and microbiology, cancer, human genetics, and disease. Cell's distinct narrative format allows authors to tell a full and complete story, plus creates a unique opportunity to promote interdisciplinary thinking across fields. (

Current Biology, launched in February of 1991, and became part of Cell Press in early 2001. This journal delivers high-impact research in all areas of biology, from molecular biology to evolution. Current Biology's broad scope, top-flight research papers, and engaging magazine section set it apart as a distinctive leading journal. (

Established in 1949, the American Journal of Human Genetics, is published monthly by Cell Press. This journal provides a record of research and review relating to heredity in humans and to the application of genetic principles in medicine and public policy, as well as in related areas of molecular and cell biology. (


Contact: Cathleen Genova
Cell Press

Related biology news :

1. Three-way mating game of North American lizard found in distant European relative
2. Columbia to award 2007 Horwitz Prize to three generations of teacher-student scientists
3. Stevens researchers provide oversight for three-year mariculture program in Egypt and Israel
4. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
5. Researchers document rapid, dramatic reverse evolution in the threespine stickleback fish
6. Scientists integrate data in three dimensions to study climate effects on young fish
7. Wetlands expert: China should think outside the flooding box with Three Gorges Dam
8. Dwarf crocodiles split into three species
9. Joslin research finds nearly three-quarters of youths with diabetes insufficient in vitamin D
10. Four, three, two, one . . . pterosaurs have lift off
11. Tiny details in three dimensions
Post Your Comments:
(Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
(Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology: